Analysts have been eager to weigh in on the Healthcare sector with new ratings on Conmed (CNMD – Research Report), Roche Holding AG (RHHVF – Research Report) and Sanofi (SNYNF – Research Report).
Conmed (CNMD)
In a report released today, Michael Matson from Needham maintained a Buy rating on Conmed, with a price target of $129.00. The company’s shares closed last Wednesday at $95.60, close to its 52-week low of $88.01.
According to TipRanks.com, Matson is a 1-star analyst with an average return of
Conmed has an analyst consensus of Moderate Buy, with a price target consensus of $117.75.
See today’s best-performing stocks on TipRanks >>
Roche Holding AG (RHHVF)
Morgan Stanley analyst Mark Purcell maintained a Sell rating on Roche Holding AG today and set a price target of CHF260.00. The company’s shares closed last Wednesday at $283.44.
According to TipRanks.com, Purcell is a 4-star analyst with an average return of
Currently, the analyst consensus on Roche Holding AG is a Hold with an average price target of $314.52, a 10.6% upside from current levels. In a report issued on January 19, J.P. Morgan also maintained a Sell rating on the stock with a CHF230.00 price target.
Sanofi (SNYNF)
Bank of America Securities analyst Graham Parry maintained a Buy rating on Sanofi today and set a price target of $65.00. The company’s shares closed last Wednesday at $101.00.
Parry has an average return of
According to TipRanks.com, Parry is ranked #4978 out of 8689 analysts.
Sanofi has an analyst consensus of Moderate Buy, with a price target consensus of $99.05, representing a -1.9% downside. In a report issued on January 23, UBS also maintained a Buy rating on the stock with a EUR110.00 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on CNMD:
